|
Public Attitudes About Genetic Testing For Alzheimers Disease
Peter J. Neumann,
James K. Hammitt,
Curt Mueller,
Howard M. Fillit,
Jerrold Hill,
Nii A. Tetteh and
Kenneth S. Kosik
In a general population survey (N = 314), 79 percent of respondents stated that they would take a hypothetical genetic test to predict whether they will eventually develop Alzheimers disease. The proportion fell to 45 percent for a "partially predictive" test (which had a one in ten chance of being incorrect). Inclination to obtain testing was similar across age groups. Respondents were willing to pay $324 for the completely predictive test. Respondents stated that if they tested positive, they would sign advance directives (84 percent), get their finances in order (74 percent), and purchase long-term care insurance (69 percent). Only a third of respondents expressed concern about confidentiality. The results suggest that people value genetic testing for personal and financial reasons, but they also underscore the need to counsel potential recipients carefully about the accuracy and implications of test information.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. C. Green, J. S. Roberts, L. A. Cupples, N. R. Relkin, P. J. Whitehouse, T. Brown, S. L. Eckert, M. Butson, A. D. Sadovnick, K. A. Quaid, et al.
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
N. Engl. J. Med.,
July 16, 2009;
361(3):
245 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Miller
Public Understanding of, and Attitudes toward, Scientific Research: What We Know and What We Need to Know
Public Understanding of Science,
July 1, 2004;
13(3):
273 - 294.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Cutler and L. G. Hodgson
To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults
American Journal of Alzheimer's Disease and Other Dementias,
January 1, 2003;
18(1):
9 - 20.
[Abstract]
[PDF]
|
 |
|
|